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NOT PRECEDENTIAL 
 
UNITED STATES COURT OF APPEALS 
FOR THE THIRD CIRCUIT 
________________ 
 
No. 17-1843 
 
 
U.S. RENAL CARE INC. 
d/b/a U.S. RENAL CARE CENTRAL 
YORK DIALYSIS individually and as ASSIGNEE 
OF PATIENT, WW, 
 
       Appellant 
v. 
  
WELLSPAN HEALTH; WELLSPAN MEDICAL PLAN; 
THE PLAN ADMINISTRATOR OF WELLSPAN MEDICAL PLAN; 
SOUTH CENTRAL PREFERRED, INC. 
 
     ________________ 
 
Appeal from the United States District Court 
for the Middle District of Pennsylvania 
(D.C. Civil Action No. 1-14-cv-02257) 
District Judge: Honorable Sylvia H. Rambo 
 
 
Submitted Under Third Circuit L.A.R. 34.1(a) 
January 16, 2018 
 
 
Before: AMBRO, RESTREPO, and FUENTES, Circuit Judges 
 
 
(Opinion filed: January 24, 2018) 
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________________ 
 
OPINION* 
________________ 
 
AMBRO, Circuit Judge 
 
U.S. Renal Care, Inc. appeals the District Court’s grant of summary judgment in 
favor of WellSpan Health, WellSpan Medical Plan, and South Central Preferred 
(collectively “WellSpan”).1  Renal Care argues the Court erroneously held WellSpan 
established an equitable lien by agreement for the reimbursement of its mistaken 
overpayment to Renal Care for dialysis services it provided to a plan beneficiary.  It also 
argues there is a material factual dispute over whether it received a May 2013 mailing 
from WellSpan containing documents to support the latter’s refund request.2 
We have jurisdiction over final orders of the District Court under 29 U.S.C. 
§ 1291.  We review its grant of summary judgment de novo and apply the same standard 
it used.  See Fakete v. Aetna, Inc., 308 F.3d 335, 337 (3d Cir. 2002).  Summary judgment 
is proper if, viewing the record in the light most favorable to Renal Care, there is no 
                                              
* This disposition is not an opinion of the full Court and pursuant to I.O.P. 5.7 does not 
constitute binding precedent. 
1 We do not address the issues Renal Care raises in its Statement of Issues or Argument 
headings for which it does not present an argument in its opening brief; we consider those 
issues abandoned and waived.  See Free Speech Coal., Inc. v. Att’y Gen., 677 F.3d 519, 
545 (3d Cir. 2012). 
 
2 Renal Care also contends there is a factual dispute as to WellSpan’s demand for 
reimbursement of overpayments due to a second set of clerical errors.  However, its 
assertion that WellSpan issued its demand before those errors occurred is contrary to the 
record.  J.A. at 340–43. 
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genuine issue of material fact and WellSpan is entitled to judgment as a matter of law.  
Id.; Fed. R. Civ. P. 56(a).   
We affirm the District Court’s holding that WellSpan established an equitable lien 
by agreement.  The Court correctly relied on Funk v. CIGNA, which held an agreement 
that states the plaintiff was responsible for reimbursement of the full amount of any 
overpayment was sufficient to create an equitable lien by agreement.  Funk v. CIGNA 
Grp. Ins., 648 F.3d 182, 194–95 (3d Cir. 2011).  Though it was abrogated on other 
grounds by Montanile v. Board of Trustees, this portion of Funk’s holding remains good 
support.  See Montanile v. Bd. of Trs. of Nat’l Elevator Indus. Health Benefit Plan, 136 S. 
Ct. 651 (2016).  Even assuming the beneficiary’s assignment to Renal Care was valid, it 
stands in the shoes of the beneficiary with respect to the agreement between him and 
WellSpan regarding reimbursement.  See CardioNet, Inc. v. CIGNA Health Corp., 751 
F.3d 165, 178 (3d Cir. 2014).  WellSpan’s equitable lien by agreement thus arose from its 
contractual right to overpayment.  See US Airways, Inc. v. McCutchen, 569 U.S. 88, 95–
96 (2013).  
Renal Care’s commingling of WellSpan’s overpayments with other moneys in its 
operating account does not make the overpayments untraceable.  See, e.g., Sereboff v. 
Mid Atl. Med. Servs., Inc., 547 U.S. 356, 362–63 (2006) (holding portion of beneficiary’s 
settlement constituted specifically identifiable funds subject to equitable lien).  WellSpan 
identified a specific fund in Renal Care’s possession (its operating account) and the 
particular share of that fund to which it is entitled (the amount of the overpayments).  See 
Montanile, 136 S. Ct. at 660 (interpreting Sereboff, 547 U.S. at 364–65).  
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Finally, there is no material factual dispute over whether Renal Care received the 
May 2013 mailing from WellSpan.  The Court correctly applied the “mailbox rule” that a 
document is presumed to have reached its destination at the regular time and been 
received by the person to whom it was addressed if it was proved to have been properly 
directed and put into the post office or delivered to the mail carrier.  See Lupyan v. 
Corinthian Colls. Inc., 761 F.3d 314, 319 (3d Cir. 2014).  Renal Care failed to rebut the 
presumption of receipt because it solely relied on a sworn statement by a Renal Care 
employee who was not employed at the time the letters were mailed and had no personal 
knowledge of the mailing or Renal Care’s intake procedures at the time.  
Thus we affirm. 
